Medication-assisted treatment for opioid dependence: making a difference in prisons

Area of Science:

• Addiction Medicine
• Public Health
• Criminal Justice Health

Background:

• Opioid use disorder (OUD) is prevalent in correctional facilities.
• Access to evidence-based treatment is often limited for incarcerated individuals.
• Continuity of care for OUD is a significant public health challenge.

Purpose of the Study:

• To examine the current evidence base for opioid maintenance therapies (OMT) in incarcerated populations.
• To assess the benefits and challenges of implementing OMT within correctional settings.
• To inform policy and practice regarding OUD treatment in prisons and jails.

Main Methods:

• Systematic review of existing literature.
• Analysis of studies on methadone, buprenorphine, and naltrexone in correctional settings.
• Evaluation of treatment outcomes, including retention, relapse, and overdose risk.

Main Results:

• Evidence supports the efficacy and safety of OMT for incarcerated individuals.
• OMT is associated with reduced illicit opioid use, disease transmission, and mortality post-release.
• Implementation challenges include medication access, staffing, and community reintegration.

Conclusions:

• Opioid maintenance therapies are a critical component of comprehensive OUD care for incarcerated populations.
• Expanding access to OMT in correctional facilities can improve individual and public health outcomes.
• Further research and policy development are needed to ensure effective implementation and continuity of care.